Skip to main content
EVLV $5.80 +0.69%
EVLV logo

EVLV · Evolv Technologies Holdings, Inc.

Track EVLV — free
$5.80 +0.04 (+0.69%) At close · Aug 14
Market Cap
$1.05B
Shares
181.13M
All earnings calls

Earnings call · FY2024 Q1

Evolv Technologies Holdings, Inc. Q1 FY2024 Earnings Call

Evolv Technologies Holdings, Inc. Q1 FY2024 Earnings Call

Concluded May 9, 2024
May 9, 2024 36 turns
Period
FY2024 Q1
Runtime
Sources
3 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Regulatory and media overhang 32 Recurring revenue and subscription model 25 Vertical markets (healthcare and education) 21 Sales cycle lengthening and deal slippage 13 Channel partners and go-to-market 8 Profitability path 8

Management tone

Positive

Net tone +15 · moderate hedging

Grounding quotes
  • “While we believe the regulatory overhang has lengthened the sales cycle, it does not appear to be impacting our win rate.”
  • “For that reason, we think it's prudent to be a bit more cautious in our annual outlook.”
  • “the year started a little bit lighter and slower than we expected. There certainly has been a lot of evidence of regulatory overhang, which is shown up in that expanded sales cycle from three months to five months and we're dealing with that.”
  • “It has, however, made it a bit more challenging to provide forecasts in the near term since possible deal slippage is, by its nature, uncertain.”

Forward guidance

4 guided metrics

Management's latest ranges and targets are included below.

Research coverage

3 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $22.18M +10.2% YoY
Diluted EPS -$0.07
Gross margin 54.8% +32.2 pp YoY
Net income -$11.27M

Research materials

Open the source you need; every reader stays inside this workspace.

Guidance from the call

Stated verbally and extracted from the transcript.

Metric Guided Actual
Full-year revenues Initiated
full-year 2024
$100M $103.87M above
ARR
exit 2024
$100M
Adjusted full-year gross margin Initiated
full-year 2024
60%
Full-year adjusted EBITDA improvement Initiated
full-year 2024
at least 40%
Full-screen source Call document